Swk Holdings Corp - 9% NT REDEEM 31/01/2027 USD 25
SWKHL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$192.79M
Close$
$67.75
169.1% upside
Current Fair Value
169.1% upsideUndervalued by 169.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $192.79 Million |
|---|---|
| Enterprise Value | $182.13 Million |
| Annual dividend | $2.25 |
| Dividend yield | 8.94% |
| Earnings per Share | $-0.21 |
| Beta | 0.06 |
| Outstanding Shares | 12,162,000 |
Return
| Return on Equity | -1.08% |
|---|---|
| Return on Assets | -0.93% |
| Return on Invested Capital | 9.32% |
Valuation & Multiples
| P/E Ratio | -43.41 |
|---|---|
| PEG | 10.09 |
| Price to Sales | 8.39 |
| Price to Book Ratio | 1.33 |
| Enterprise Value to Revenue | 4.47 |
| Enterprise Value to EBIT | 7.31 |
| Enterprise Value to Net Income | -72 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$0.53
Consensus analyst estimateRevenue Estimate
$8.69 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.53
Consensus analyst estimateRevenue Estimate
$8.69 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Swk Holdings Corp
16 employees
swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow ...